• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Production of Influenza Virus HA1 Harboring Native-Like Epitopes by Pichia pastoris

tetano

Editor, Senior Moderator
Appl Biochem Biotechnol. 2016 Apr 4. [Epub ahead of print]
[h=1]Production of Influenza Virus HA1 Harboring Native-Like Epitopes by Pichia pastoris.[/h] Lin Q[SUP]1[/SUP], Yang K[SUP]1[/SUP], He F[SUP]1[/SUP], Jiang J[SUP]1[/SUP], Li T[SUP]1[/SUP], Chen Z[SUP]2[/SUP], Li R[SUP]1[/SUP], Chen Y[SUP]1,[/SUP][SUP]2[/SUP], Li S[SUP]3,[/SUP][SUP]4[/SUP], Zhao Q[SUP]5[/SUP], Xia N[SUP]1,[/SUP][SUP]2[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] The outbreak of the H5N1 highly pathogenic avian influenza which exhibits high variation had brought a serious threat to the safety of humanity. To overcome this high variation, hemagglutinin-based recombinant subunit vaccine with rational design has been considered as a substitute for traditional virion-based vaccine development. Here, we expressed HA1 part of the hemagglutinin protein using the Pichia pastoris expression system and attained a high yield of about 120 mg/L through the use of fed-batch scalable fermentation. HA1 protein in the culture supernatant was purified using two-step ion-exchange chromatography. The resultant HA1 protein was homogeneous in solution in a glycosylated form, as confirmed by endoglycosidase H treatment. Sedimentation velocity tests, silver staining of protein gels, and immunoblotting were used for verification. The native HA1 reacted well with conformational, cross-genotype, neutralizing monoclonal antibodies, whereas a loss of binding activity was noted with the denatured HA1 form. Moreover, the murine anti-HA1 serum exhibited a virus-capture capability in the hemagglutination inhibition assay, which suggests that HA1 harbors native-like epitopes. In conclusion, soluble HA1 was efficiently expressed and purified in this study. The functional glycosylated protein will be an alternative for the development of recombinant protein-based influenza vaccine.


[h=4]KEYWORDS:[/h] Fed-batch fermentation; Hemagglutinin; Monoclonal antibody; Native epitopes; Pichia pastoris

PMID: 27040529 [PubMed - as supplied by publisher]
 
Back
Top Bottom